Indication intelligence, analysis and sector perception

Lower expected; RegMed, cry me a river …

February 19, 2016 11:02am

Another I told you so …

Subscribe … http://www.regmedinvestors.com/create-account

I say today what others won't, so you can do what others can't; whether information or intelligence is good, bad or somewhere in between – it defines the who, when, which and what of it …

Sorry, I missed last nights wrap-up and the morning post but, immediate family circumstances mandated an out-of-state travel

The stem, cell and gene therapy RegMed sector closed NEGATIVE on ThursdayPOSITIVE on Wednesday, Tuesday and Friday following a NEGATIVE close on last Thursday.

Past five (5) days (of 43 covered companies):

· Thursday closed NEGATIVE with 19 decliners, 11 advancers and 3 flat;

· Wednesday closed POSITIVE with 3 decliners, 37 advancers and 3 flats;

· Tuesday closed POSITIVE with 6 decliners, 36 advancers and 1 flat;

· Monday was a holiday;

· Last, Friday closed POSITIVE with 11 decliners, 28 advancers and 4 flats

An old Wall Street saying is that a rising tide lifts all boats, but no matter which way the market is moving, there are stocks that will always go their own way.

You’ve made it to the office, turned on the monitor having just gotten your coffee and it hits you - what are today’s trades?

MY view is there is no other interpretation than to assume the trend remains to the downside.

STAY on the sidelines - dangerous to SELL and or BUY!

Opinions expressed are those of the author and are subject to change, and are not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.